Is hyperhomocysteinemia a risk factor for osteoporosis?

Expert Review of Endocrinology and Metabolism

Volumn 3, Issue 3, 2008, Pages 309-313

  Herrmann, Wolfgang ^a   Herrmann, Markus ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

B vitamins; Folate; Homocysteine; Intervention trial; Osteoporosis; Risk reduction; Vitamin B12; Vitamin B6; Vitamin treatment

Indexed keywords

COLLAGEN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; PLACEBO; PYRIDOXINE; VITAMIN B GROUP;

ARTICLE; BONE DENSITY; BONE MATRIX; BONE METABOLISM; BONE TURNOVER; CARDIOVASCULAR DISEASE; CELL ACTIVITY; CELL CULTURE; CELL STIMULATION; CLINICAL TRIAL; FRACTURE; HIP FRACTURE; HUMAN; HYPERHOMOCYSTEINEMIA; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RISK FACTOR; VITAMIN DEFICIENCY;

EID: 55649083493     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/17446651.3.3.309     Document Type: Article

References (33)

1. Gerritson T, Vaughn JG, Waisman HA. The identification of homocystine in the urine. Biochem. Biophys. Res. Commun. 9, 493-496 (1962).
2. Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: An enzymatic defect. Science 143, 1443-1445 (1964).
3. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56, 111-128 (1969).
4. McKusick VA. Herritable Disorders of Connective Tissue. CV Mosby, MO, USA 155 (1966).
5. Carson NAJ, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch. Dis. Child. 37, 505-513 (1962).
6. Parrot F, Redonnet-Vernhet I, Lacombe D, Gin H. Osteoporosis in late-diagnosed adult homocystinuric patients. J. Inherit. Metab. Dis. 23, 338-340 (2000).
7. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM et al. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 350, 2033-2041 (2004).
8. McLean RR, Jacques PF, Selhub J et al. Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 350, 2042-2049 (2004).
9. Goerss JB, Kim CH, Atkinson EJ, Eastell R, O'Fallon WM, Melton LJ 3rd. Risk of fractures in patients with pernicious anemia. J. Bone Miner. Res. 7, 573-579 (1992).
10. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women. Clin. Chem. Lab. Med. 43, 1118-1123 (2005).
11. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167, S1-S34 (2002).
12. Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 33, 956-959 (2003).
13. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: A cross-sectional study. Bone 35, 760-765 (2004).
14. Small RE. Uses and limitations of bone mineral density measurements in the management of osteoporosis. Med. Gen. Med. 7, 3 (2005).
15. Briot K, Roux C. What is the role of DXA, QUS and bone markers in fracture prediction, treatment allocation and monitoring? Best. Pract. Res. Clin. Rheumatol. 19, 951-964 (2005).
16. Dhonukshe-Rutten BA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J. Bone Miner. Res. 20, 921-929 (2005).
17. Bode MK, Laitinen P, Risteli J, Uusimaa P, Juvonen T. Atherosclerosis, type 1 collagen cross-linking and homocysteine. Atherosclerosis 152, 531-532 (2000).
18. Gerdhem P, Ivaska KK, Isaksson A et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J. Bone Miner. Res. 22, 127-134 (2007).
19. Nilsson K, Gustafson L, Isaksson A, Hultberg B. Plasma homocysteine and markers of bone metabolism in psychogeriatric patients. Scand. J. Clin. Lab. Invest. 65, 671-680 (2005).
20. Abrahamsen B, Jorgensen HL, Nielsen TL et al. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men - results from the Odense Androgen Study. Bone 38, 215-219 (2006).
21. Perier MA, Gineyts E, Munoz F, Sornay-Rendu E, Delmas PD. Homocysteine and fracture risk in postmenopausal women: The OFELY study. Osteoporos. Int. 18, 1329-1336 (2007).
22. Kuriyama M, Ueno K, Uno H et al. Clinical evaluation of serum prostate-specific antigen-α1-antichymotrypsin complex values in diagnosis of prostate cancer: A cooperative study. Int. J. Urol. 5, 48-54 (1998).
23. Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: A 2-y randomized controlled trial. Am. J. Clin. Nutr. 85, 460-464 (2007).
24. Herrmann M, Stanger O, Paulweber B, Hufnagl C, Herrmann W. Folate supplementation does not affect biochemical markers of bone turnover. Clin. Lab. 52, 131-136 (2006).
25. Herrmann M, Umanskaya N, Traber L et al. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients - an one year double blind placebo controlled trial. Clin. Chem. Lab. Med. 45, 1785-1792 (2007).
26. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: A randomized controlled trial. JAMA 293, 1082-1088 (2005).
27. Ozdem S, Samanci N, Tasatargil A et al. Experimental hyperhomocysteinemia disturbs bone metabolism in rats. Scand. J. Clin. Lab. Invest. 67, 748-756 (2007).
28. Herrmann M, Wildemann B, Claes L et al. Experimental hyperhomocysteinemia reduces bone quality in rats. Clin. Chem. 53, 1455-1461 (2007).
29. Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR. Cobalamin and osteoblast-specific proteins. N. Engl. J. Med. 319, 70-75 (1988).
30. 12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 45, 1443-1446 (1996).
31. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin. Chem. 51, 2348-2353 (2005).
32. Koh JM, Lee YS, Kim YS et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J. Bone Miner. Res. 21, 1003-1011 (2006).
33. Herrmann M, Schmidt J, Umanskaya N et al. Stimulation of osteoclast activity by low B-vitamin concentrations. Bone 41, 581-592 (2007).